Home › Studies › PRJNA755324
PRJNA755324 SRP333172

VE303 Live Biotherapeutic in Healthy Adults, Baltimore

Colonization of the Live Biotherapeutic Product VE303 and Modulation of the Microbiota and Metabolites in Healthy Volunteers

450 stool metagenome samples from healthy adult volunteers in Baltimore, USA, in an intervention study evaluating antibiotic pretreatment and colonization by the live biotherapeutic product VE303. machine-written summary

450 samples · 450 runs · US · Adult · 2022 · 6.32 Gbp / sample

Sources
✓Sequence archive 3,728○Abstract / description○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive3,728 sample values (collection date, country, intervention, intervention detail, latitude, location locality, location region, longitude)
○ Abstract / descriptionread; no usable statement
○ Full textread; no usable statement or table · PMC12736906, PMC12919772
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Antibiotic given as the study intervention (incl. eradication therapy Defined bacterial consortium / live biotherapeutic product design randomized_controlled_trial · population healthy_control · VE303 (8-strain LBP) dosed after vancomycin pretreatment, phase 1a/b

“VE303 strains optimally colonize HVs if dosed over multiple days after vancomycin” — abstract:35421353 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
adult450
Country
US450
Body site
primary450
Collected 2017–2019
2017: 32 samples2018: 392 samples2019: 26 samples20172019
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 1 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 423 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 25 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)this project, 30–100 Gbp: 1 samplesall projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 6.32 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

32 of 32 people sampled more than once (450 samples; median 14, up to 17 per person) · follow-up median 12 mo (max 13 mo) · median interval between samples 7 d (time from collection dates). Schedule stated by the source: “Samples collected at Screening, Day -1, Day 0, Day 02, Day 04, Day 05, Day 06, Day 08, Day 10, Week 4, Week 6, Week 8, Week 12, Week 52 and other timepoints per subject”; stated follow-up 12 mo.

Cohort 1; SubjecCohort 1; Subject 53: day 0Cohort 1; Subject 53: day 13Cohort 1; Subject 53: day 18Cohort 1; Subject 53: day 19Cohort 1; Subject 53: day 20Cohort 1; Subject 53: day 21Cohort 1; Subject 53: day 22Cohort 1; Subject 53: day 42Cohort 1; Subject 53: day 56Cohort 1; Subject 53: day 71Cohort 1; Subject 53: day 98Cohort 1; Subject 53: day 377Cohort 1; SubjecCohort 1; Subject 59: day 0Cohort 1; Subject 59: day 12Cohort 1; Subject 59: day 16Cohort 1; Subject 59: day 17Cohort 1; Subject 59: day 18Cohort 1; Subject 59: day 20Cohort 1; Subject 59: day 21Cohort 1; Subject 59: day 41Cohort 1; Subject 59: day 55Cohort 1; Subject 59: day 69Cohort 1; Subject 59: day 97Cohort 1; Subject 59: day 283Cohort 1; Subject 59: day 376Cohort 2; SubjecCohort 2; Subject 35: day 0Cohort 2; Subject 35: day 20Cohort 2; Subject 35: day 24Cohort 2; Subject 35: day 25Cohort 2; Subject 35: day 26Cohort 2; Subject 35: day 27Cohort 2; Subject 35: day 29Cohort 2; Subject 35: day 49Cohort 2; Subject 35: day 63Cohort 2; Subject 35: day 78Cohort 2; Subject 35: day 103Cohort 2; Subject 35: day 291Cohort 2; Subject 35: day 384Cohort 2; SubjecCohort 2; Subject 55: day 0Cohort 2; Subject 55: day 15Cohort 2; Subject 55: day 18Cohort 2; Subject 55: day 20Cohort 2; Subject 55: day 20Cohort 2; Subject 55: day 22Cohort 2; Subject 55: day 23Cohort 2; Subject 55: day 43Cohort 2; Subject 55: day 57Cohort 2; Subject 55: day 72Cohort 2; Subject 55: day 99Cohort 2; Subject 55: day 285Cohort 2; Subject 55: day 378Cohort 2; SubjecCohort 2; Subject 69: day 0Cohort 2; Subject 69: day 14Cohort 2; Subject 69: day 18Cohort 2; Subject 69: day 19Cohort 2; Subject 69: day 20Cohort 2; Subject 69: day 21Cohort 2; Subject 69: day 23Cohort 2; Subject 69: day 42Cohort 2; Subject 69: day 58Cohort 2; Subject 69: day 70Cohort 2; Subject 69: day 100Cohort 3; SubjecCohort 3; Subject 100: day 0Cohort 3; Subject 100: day 10Cohort 3; Subject 100: day 13Cohort 3; Subject 100: day 14Cohort 3; Subject 100: day 15Cohort 3; Subject 100: day 16Cohort 3; Subject 100: day 18Cohort 3; Subject 100: day 38Cohort 3; Subject 100: day 53Cohort 3; Subject 100: day 66Cohort 3; Subject 100: day 94Cohort 3; Subject 100: day 266Cohort 3; Subject 100: day 371Cohort 3; SubjecCohort 3; Subject 102: day 0Cohort 3; Subject 102: day 10Cohort 3; Subject 102: day 13Cohort 3; Subject 102: day 14Cohort 3; Subject 102: day 18Cohort 3; Subject 102: day 19Cohort 3; Subject 102: day 20Cohort 3; Subject 102: day 36Cohort 3; Subject 102: day 53Cohort 3; SubjecCohort 3; Subject 67: day 0Cohort 3; Subject 67: day 15Cohort 3; Subject 67: day 18Cohort 3; Subject 67: day 19Cohort 3; Subject 67: day 20Cohort 3; Subject 67: day 21Cohort 3; Subject 67: day 23Cohort 3; Subject 67: day 43Cohort 3; Subject 67: day 58Cohort 3; Subject 67: day 72Cohort 3; Subject 67: day 100Cohort 3; Subject 67: day 272Cohort 3; Subject 67: day 376Cohort 4; SubjecCohort 4; Subject 110: day 0Cohort 4; Subject 110: day 19Cohort 4; Subject 110: day 22Cohort 4; Subject 110: day 24Cohort 4; Subject 110: day 25Cohort 4; Subject 110: day 27Cohort 4; Subject 110: day 29Cohort 4; Subject 110: day 33Cohort 4; Subject 110: day 45Cohort 4; Subject 110: day 58Cohort 4; Subject 110: day 74Cohort 4; Subject 110: day 106Cohort 4; Subject 110: day 255Cohort 4; Subject 110: day 381Cohort 4; SubjecCohort 4; Subject 111: day 0Cohort 4; Subject 111: day 18Cohort 4; Subject 111: day 23Cohort 4; Subject 111: day 24Cohort 4; Subject 111: day 25Cohort 4; Subject 111: day 28Cohort 4; Subject 111: day 29Cohort 4; Subject 111: day 33Cohort 4; Subject 111: day 46Cohort 4; Subject 111: day 63Cohort 4; Subject 111: day 77Cohort 4; Subject 111: day 101Cohort 4; Subject 111: day 382Cohort 4; SubjecCohort 4; Subject 126: day 0Cohort 4; Subject 126: day 19Cohort 4; Subject 126: day 23Cohort 4; Subject 126: day 24Cohort 4; Subject 126: day 25Cohort 4; Subject 126: day 27Cohort 4; Subject 126: day 29Cohort 4; Subject 126: day 33Cohort 4; Subject 126: day 46Cohort 4; Subject 126: day 59Cohort 4; Subject 126: day 72Cohort 4; Subject 126: day 100Cohort 4; Subject 126: day 252Cohort 4; Subject 126: day 380Cohort 4; SubjecCohort 4; Subject 132: day 0Cohort 4; Subject 132: day 17Cohort 4; Subject 132: day 20Cohort 4; Subject 132: day 22Cohort 4; Subject 132: day 23Cohort 4; Subject 132: day 25Cohort 4; Subject 132: day 27Cohort 4; Subject 132: day 31Cohort 4; Subject 132: day 44Cohort 4; Subject 132: day 57Cohort 4; Subject 132: day 70Cohort 4; Subject 132: day 99Cohort 4; Subject 132: day 254Cohort 4; Subject 132: day 379Cohort 4; SubjecCohort 4; Subject 133: day 0Cohort 4; Subject 133: day 17Cohort 4; Subject 133: day 20Cohort 4; Subject 133: day 22Cohort 4; Subject 133: day 23Cohort 4; Subject 133: day 25Cohort 4; Subject 133: day 27Cohort 4; Subject 133: day 31Cohort 4; Subject 133: day 44Cohort 4; Subject 133: day 58Cohort 4; Subject 133: day 72Cohort 4; Subject 133: day 99Cohort 4; Subject 133: day 250Cohort 4; Subject 133: day 376Cohort 4; SubjecCohort 4; Subject 144: day 0Cohort 4; Subject 144: day 15Cohort 4; Subject 144: day 18Cohort 4; Subject 144: day 20Cohort 4; Subject 144: day 21Cohort 4; Subject 144: day 23Cohort 4; Subject 144: day 25Cohort 4; Subject 144: day 29Cohort 4; Subject 144: day 42Cohort 4; Subject 144: day 56Cohort 4; Subject 144: day 68Cohort 4; Subject 144: day 96Cohort 4; Subject 144: day 395Cohort 5; SubjecCohort 5; Subject 153: day 0Cohort 5; Subject 153: day 21Cohort 5; Subject 153: day 26Cohort 5; Subject 153: day 26Cohort 5; Subject 153: day 27Cohort 5; Subject 153: day 29Cohort 5; Subject 153: day 31Cohort 5; Subject 153: day 35Cohort 5; Subject 153: day 40Cohort 5; Subject 153: day 44Cohort 5; Subject 153: day 47Cohort 5; Subject 153: day 54Cohort 5; Subject 153: day 63Cohort 5; Subject 153: day 77Cohort 5; Subject 153: day 105Cohort 5; Subject 153: day 231Cohort 5; Subject 153: day 379Cohort 5; SubjecCohort 5; Subject 156: day 0Cohort 5; Subject 156: day 21Cohort 5; Subject 156: day 25Cohort 5; Subject 156: day 26Cohort 5; Subject 156: day 27Cohort 5; Subject 156: day 29Cohort 5; Subject 156: day 31Cohort 5; Subject 156: day 36Cohort 5; Subject 156: day 40Cohort 5; Subject 156: day 44Cohort 5; Subject 156: day 47Cohort 5; Subject 156: day 54Cohort 5; Subject 156: day 63Cohort 5; Subject 156: day 76Cohort 5; Subject 156: day 108Cohort 5; Subject 156: day 231Cohort 5; Subject 156: day 381Cohort 5; SubjecCohort 5; Subject 157: day 0Cohort 5; Subject 157: day 21Cohort 5; Subject 157: day 25Cohort 5; Subject 157: day 26Cohort 5; Subject 157: day 27Cohort 5; Subject 157: day 29Cohort 5; Subject 157: day 31Cohort 5; Subject 157: day 35Cohort 5; Subject 157: day 40Cohort 5; Subject 157: day 44Cohort 5; Subject 157: day 47Cohort 5; Subject 157: day 53Cohort 5; Subject 157: day 65Cohort 5; Subject 157: day 80Cohort 5; Subject 157: day 106Cohort 5; Subject 157: day 239Cohort 5; Subject 157: day 381Cohort 5; SubjecCohort 5; Subject 158: day 0Cohort 5; Subject 158: day 21Cohort 5; Subject 158: day 25Cohort 5; Subject 158: day 26Cohort 5; Subject 158: day 27Cohort 5; Subject 158: day 29Cohort 5; Subject 158: day 31Cohort 5; Subject 158: day 35Cohort 5; Subject 158: day 40Cohort 5; Subject 158: day 44Cohort 5; Subject 158: day 48Cohort 5; Subject 158: day 55Cohort 5; Subject 158: day 65Cohort 5; Subject 158: day 79Cohort 5; Subject 158: day 107Cohort 5; Subject 158: day 231Cohort 5; Subject 158: day 381Cohort 5; SubjecCohort 5; Subject 166: day 0Cohort 5; Subject 166: day 17Cohort 5; Subject 166: day 21Cohort 5; Subject 166: day 22Cohort 5; Subject 166: day 23Cohort 5; Subject 166: day 25Cohort 5; Subject 166: day 27Cohort 5; Subject 166: day 31Cohort 5; Subject 166: day 36Cohort 5; Subject 166: day 40Cohort 5; Subject 166: day 43Cohort 5; Subject 166: day 50Cohort 5; Subject 166: day 61Cohort 5; Subject 166: day 74Cohort 5; Subject 166: day 101Cohort 5; Subject 166: day 228Cohort 5; Subject 166: day 375Cohort 5; SubjecCohort 5; Subject 171: day 0Cohort 5; Subject 171: day 15Cohort 5; Subject 171: day 19Cohort 5; Subject 171: day 20Cohort 5; Subject 171: day 21Cohort 5; Subject 171: day 23Cohort 5; Subject 171: day 25Cohort 5; Subject 171: day 29Cohort 5; Subject 171: day 34Cohort 5; Subject 171: day 38Cohort 5; Subject 171: day 41Cohort 5; Subject 171: day 51Cohort 5; Subject 171: day 56Cohort 5; Subject 171: day 71Cohort 5; Subject 171: day 99Cohort 5; Subject 171: day 225Cohort 5; Subject 171: day 373Cohort 5; SubjecCohort 5; Subject 176: day 0Cohort 5; Subject 176: day 15Cohort 5; Subject 176: day 19Cohort 5; Subject 176: day 20Cohort 5; Subject 176: day 21Cohort 5; Subject 176: day 23Cohort 5; Subject 176: day 25Cohort 5; Subject 176: day 29Cohort 5; Subject 176: day 34Cohort 5; Subject 176: day 38Cohort 5; Subject 176: day 41Cohort 5; Subject 176: day 48Cohort 5; Subject 176: day 58Cohort 5; Subject 176: day 71Cohort 5; Subject 176: day 101Cohort 5; Subject 176: day 228Cohort 5; Subject 176: day 375Cohort 6; SubjecCohort 6; Subject 191: day 0Cohort 6; Subject 191: day 15Cohort 6; Subject 191: day 18Cohort 6; Subject 191: day 22Cohort 6; Subject 191: day 29Cohort 6; Subject 191: day 36Cohort 6; Subject 191: day 38Cohort 6; Subject 191: day 39Cohort 6; Subject 191: day 44Cohort 6; Subject 191: day 51Cohort 6; Subject 191: day 58Cohort 6; Subject 191: day 72Cohort 6; Subject 191: day 98Cohort 6; Subject 191: day 183Cohort 6; Subject 191: day 331Cohort 6; SubjecCohort 6; Subject 192: day 0Cohort 6; Subject 192: day 15Cohort 6; Subject 192: day 18Cohort 6; Subject 192: day 22Cohort 6; Subject 192: day 29Cohort 6; Subject 192: day 36Cohort 6; Subject 192: day 38Cohort 6; Subject 192: day 39Cohort 6; Subject 192: day 44Cohort 6; Subject 192: day 50Cohort 6; Subject 192: day 57Cohort 6; Subject 192: day 71Cohort 6; Subject 192: day 99Cohort 6; Subject 192: day 182Cohort 6; Subject 192: day 333Cohort 6; SubjecCohort 6; Subject 194: day 0Cohort 6; Subject 194: day 15Cohort 6; Subject 194: day 18Cohort 6; Subject 194: day 22Cohort 6; Subject 194: day 29Cohort 6; Subject 194: day 36Cohort 6; Subject 194: day 38Cohort 6; Subject 194: day 39Cohort 6; Subject 194: day 45Cohort 6; Subject 194: day 51Cohort 6; Subject 194: day 58Cohort 6; Subject 194: day 70Cohort 6; Subject 194: day 100Cohort 6; Subject 194: day 184Cohort 6; Subject 194: day 331Cohort 6; SubjecCohort 6; Subject 198: day 0Cohort 6; Subject 198: day 15Cohort 6; Subject 198: day 18Cohort 6; Subject 198: day 22Cohort 6; Subject 198: day 29Cohort 6; Subject 198: day 36Cohort 6; Subject 198: day 38Cohort 6; Subject 198: day 39Cohort 6; Subject 198: day 44Cohort 6; Subject 198: day 50Cohort 6; Subject 198: day 57Cohort 6; Subject 198: day 71Cohort 6; Subject 198: day 99Cohort 6; Subject 198: day 189Cohort 6; Subject 198: day 333Cohort 6; SubjecCohort 6; Subject 203: day 0Cohort 6; Subject 203: day 13Cohort 6; Subject 203: day 16Cohort 6; Subject 203: day 20Cohort 6; Subject 203: day 27Cohort 6; Subject 203: day 34Cohort 6; Subject 203: day 36Cohort 6; Subject 203: day 37Cohort 6; Subject 203: day 42Cohort 6; Subject 203: day 49Cohort 6; Subject 203: day 55Cohort 6; Subject 203: day 69Cohort 6; Subject 203: day 98Cohort 6; Subject 203: day 190Cohort 6; Subject 203: day 336Cohort Sentinel;Cohort Sentinel; Subject 30: day 0Cohort Sentinel; Subject 30: day 9Cohort Sentinel; Subject 30: day 12Cohort Sentinel; Subject 30: day 14Cohort Sentinel; Subject 30: day 15Cohort Sentinel; Subject 30: day 17Cohort Sentinel; Subject 30: day 17Cohort Sentinel; Subject 30: day 37Cohort Sentinel; Subject 30: day 52Cohort Sentinel; Subject 30: day 65Cohort Sentinel; Subject 30: day 93Cohort Sentinel; Subject 30: day 311Cohort Sentinel; Subject 30: day 369Cohort Vanco; SuCohort Vanco; Subject 29: day 0Cohort Vanco; Subject 29: day 9Cohort Vanco; Subject 29: day 12Cohort Vanco; Subject 29: day 14Cohort Vanco; Subject 29: day 15Cohort Vanco; Subject 29: day 16Cohort Vanco; Subject 29: day 18Cohort Vanco; Subject 29: day 37Cohort Vanco; Subject 29: day 51Cohort Vanco; Subject 29: day 65Cohort Vanco; Subject 29: day 93Cohort Vanco; Subject 29: day 303Cohort Vanco; Subject 29: day 369Cohort Vanco; SuCohort Vanco; Subject 32: day 0Cohort Vanco; Subject 32: day 8Cohort Vanco; Subject 32: day 11Cohort Vanco; Subject 32: day 12Cohort Vanco; Subject 32: day 13Cohort Vanco; Subject 32: day 14Cohort Vanco; Subject 32: day 16Cohort Vanco; Subject 32: day 36Cohort Vanco; Subject 32: day 50Cohort Vanco; Subject 32: day 63Cohort Vanco; Subject 32: day 91Cohort Vanco; Subject 32: day 301Cohort Vanco; Subject 32: day 368Cohort Vanco; SuCohort Vanco; Subject 5: day 0Cohort Vanco; Subject 5: day 11Cohort Vanco; Subject 5: day 14Cohort Vanco; Subject 5: day 16Cohort Vanco; Subject 5: day 17Cohort Vanco; Subject 5: day 18Cohort Vanco; Subject 5: day 19Cohort Vanco; Subject 5: day 38Cohort Vanco; Subject 5: day 52Cohort Vanco; Subject 5: day 66Cohort Vanco; Subject 5: day 97Cohort Vanco; Subject 5: day 374Cohort Vanco; SuCohort Vanco; Subject 64: day 0Cohort Vanco; Subject 64: day 14Cohort Vanco; Subject 64: day 18Cohort Vanco; Subject 64: day 19Cohort Vanco; Subject 64: day 20Cohort Vanco; Subject 64: day 21Cohort Vanco; Subject 64: day 23Cohort Vanco; Subject 64: day 42Cohort Vanco; Subject 64: day 56Cohort Vanco; Subject 64: day 68Cohort Vanco; Subject 64: day 97Cohort Vanco; Subject 64: day 287Cohort Vanco; Subject 64: day 376Cohort Vanco; SuCohort Vanco; Subject 65: day 0Cohort Vanco; Subject 65: day 15Cohort Vanco; Subject 65: day 19Cohort Vanco; Subject 65: day 19Cohort Vanco; Subject 65: day 20Cohort Vanco; Subject 65: day 21Cohort Vanco; Subject 65: day 23Cohort Vanco; Subject 65: day 42Cohort Vanco; Subject 65: day 58Cohort Vanco; Subject 65: day 70Cohort Vanco; Subject 65: day 96Cohort Vanco; Subject 65: day 272Cohort Vanco; Subject 65: day 3760 d3 mo6 mo10 mo13 mo

Each row is one person (32 shown); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Bacteroides 14.8%Phocaeicola 7.6%Prevotella 6.5%Klebsiella 4.2%Acidaminococcus 4.1%Roseburia 3.3%Alistipes 3.2%Faecalibacterium 2.8%Escherichia 2.1%Parabacteroides 2.1%Blautia_A 1.9%Akkermansia 1.8%not assigned to a genus 3.5%other genera 42.2%

Genera, mean relative abundance over 411 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category450 100%
country450 100%450
health_condition0 0%
subject_id450 100%450
collection_date450 100%450
detailed_location450 100%
latitude450 100%450
location_locality450 100%450
location_region450 100%450
longitude450 100%450
timepoint_label450 100%450
intervention64 14%64
intervention_detail64 14%64
Papers (3)
  • Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers. 2022 PMID 35421353 own_data
  • <i>Flavonifractor plautii</i> as a Next-Generation Probiotic Enhancing the NGP F/P Index in a Simulated Human Gut Microbiome Ecosystem. 2025 PMID 41471117 PMC12736906 own_data
  • Metabolic modeling reveals determinants of prebiotic and probiotic treatment efficacy across multiple human intervention trials. 2026 PMID 41712536 PMC12919772 unsure
Details
Archive description

VE303 isolated bacterial genome sequences and stool metagenomes from the VE303 phase 1 healthy volunteer study conducted by Vedanta Biosciences, Inc.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by sonnet_x2 with confidence 0.78. Assay shotgun_dna.

  • host study.description · “VE303 isolated bacterial genome sequences and stool metagenomes”
  • body site study.description · “stool metagenomes from the VE303 phase 1”
  • life stage study.title · “Healthy Volunteers”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN20850198collection_date2017-12-01R10.90biosample.attribute:collection_date2017-12-01
SAMN20850198countryUSR10.90sample.attr.geo_loc_nameUSA:Baltimore
SAMN20850198interventionno_interventionR10.80biosample.attribute:Study TimepointStudy Timepoint: Screening
SAMN20850198intervention_detailscreening baseline before VE303 dosingR10.80biosample.attribute:Study TimepointStudy Timepoint: Screening
SAMN20850198latitude39.2904R10.90biosample.attribute:lat_lon39.2904 N 76.6122 W
SAMN20850198location_localityBaltimoreR10.85biosample.attribute:geo_loc_nameUSA:Baltimore
SAMN20850198location_regionMarylandR10.60biosample.attribute:lat_lon39.2904 N 76.6122 W
SAMN20850198longitude-76.6122R10.90biosample.attribute:lat_lon39.2904 N 76.6122 W
SAMN20850198subject_idCohort Vanco; Subject 5R10.85sample.attr.cohort_subject_idCohort Vanco; Subject 5
SAMN20850198timepoint_labelScreeningR10.85sample.attr.study_timepointScreening
Sequencing

450 runs over 450 samples · mean 6.84 Gbp per run (median 6.32 Gbp, total 3,078.37 Gbp; 450 runs with a base count) · layout PAIRED 450 · platform ILLUMINA 450 · models NextSeq 500 (450) · 91% of runs with a Sandpiper profile · first public 2022-04-14

Authors (48)

Dsouza M first · Menon R · Crossette E · Bhattarai SK · Schneider J · Kim YG · Reddy S · Caballero S · Felix C · Cornacchione L · Hendrickson J · Watson AR · Minot SS · Greenfield N · Schopf L · Szabady R · Patarroyo J · Smith W · Harrison P · Kuijper EJ · Kelly CP · Olle B · Bobilev D · Silber JL · Bucci V · Roberts B · Faith J · Norman JM last · Shuvo MSH first · Kim S · Jo S · Rahim MA · Barman I · Hossain MS · Yoon Y · Tajdozian H · Ahmed I · Atashi A · Jeong G · Suh HS · You J · Sung C · Kim M · Seo H · Song HY last · Quinn-Bohmann N first · Carr AV · Gibbons SM last

Downloads

PRJNA755324.csv.gz (13.5 KB) · parquet (87.5 KB) — all 450 samples, every field with route and confidence · PRJNA755324_determinations.csv.gz (23.3 KB) — 3,728 evidence rows

Samples (450 · every field this project has values for · hover a cell for its source)
Loading the sample table…